A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation

Overview of attention for article published in Neuropsychiatric Disease and Treatment, May 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 47 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 130 followers.

[schizo]A 6-year open-label study of the efficacy and safety of olanzapine long-acting… http://t.co/hflutHrMe1 http://t.co/7heRwwBMIX

Reply Repost Favourite

Efficacy and safety of olanzapine long-acting injection http://t.co/TWZeyGezMU

Reply Repost Favourite

Efficacy and safety of olanzapine long-acting injection http://t.co/q1B51pIOCD

Reply Repost Favourite